In: Foley KM, Bonica JJ, Ventafridda V (eds) Proceedings of the Second International Congress of Cancer Pain. Ventafridda V, Caraceni A, Gamba A (1990) Field-testing of the WHO guidelines for cancer pain relief: summary report of demonstration projects. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Schug SA, Zech D, Dörr U (1990) Cancer pain management according to WHO analgesic guidelines. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. World Health Organization (1996) Cancer pain relief: with a guide to opioid availability, 2nd edn.
The case conference facilitates excellent communication and sharing of expertise, ensuring optimal patient care. MIPPs are valuable treatment options in patients with severe cancer pain despite use of appropriate step 3 WHO ladder medications. The documented rate of major adverse events attributable to MIPPs was 2/69 (2.9 %). At time of abstract submission, 37/63 (58.7 %) patients had died, and the mean survival post-procedure was 200 days. Patient function, mobility, and symptoms measured by the Edmonton Symptom Assessment System also improved post-procedure. Pain scores fell across all categories post-procedure. Over 80 % of procedures provided analgesic benefit. There were 103 referrals, resulting in 69 procedures performed among 63 patients. MethodsĪ retrospective review of electronic charts of all cancer patients referred to the MIPP case conference between Decemand June 25, 2013. The aims of this study are: first, to determine the benefit to patients from the procedures recommended by the case conference, and second, to explore the impact of the case conference on clinical decision-making. The twice monthly conference discusses referrals for pain control procedures and reviews imaging, with palliative care, musculoskeletal interventional radiology, radiation oncology, medical oncology, and anesthesia experts in attendance. A case conference has been created at the BC Cancer Agency to facilitate access to MIPPs for advanced cancer patients with severe pain not responding to conventional analgesics. Minimally invasive palliative procedures (MIPPs) are sometimes considered step 4 of the World Health Organization’s three-step ladder.